Latest News and Press Releases
Want to stay updated on the latest news?
-
Erelzi est le seul biosimilaire d’étanercept indiqué pour réduire les signes et les symptômes de l’arthrite psoriasique chez les patients adultes. Jusqu’à 90 000 Canadiens et Canadiennes souffrent ou...
-
Boucherville, June 19, 2018 (GLOBE NEWSWIRE) -- Sandoz Canada and Tilray finalize alliance to provide Canadians with greater access to high-quality, non-combustible medical cannabis options; Eight...
-
Sandoz Canada est la première entreprise au Canada à offrir le lévétiracétam dans une concentration de 1 000 mg, ce qui permet aux patients de réduire le nombre de comprimés à prendre...
-
Sandoz Canada is the first company in Canada to offer levetiracetam in the higher concentration 1000 mg, enabling patients to reduce the number of tablets they need to take daily.PrSandoz...
-
Click on this link to read the French version BOUCHERVILLE, QC, May 17, 2016 (GLOBE NEWSWIRE) -- Sandoz Canada announced today that it has launched on the Canadian market PrSandoz®...
-
BOUCHERVILLE, QC, March 31, 2016 (GLOBE NEWSWIRE) -- Sandoz Canada Inc. announced the launch of PrTOBRAMYCIN INHALATION SOLUTION, an authorized generic version of PrTOBI*, currently marketed by...
-
Lire la version française BOUCHERVILLE, Quebec, Dec. 7, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada announced today the launch of two easy-to-use products: Salinex® Seawater to help reduce...
-
Lire la version française BOUCHERVILLE, Quebec, Dec. 2, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada is pleased to announce the launch of (T/C)Lorazepam Injection USP 2 mg/mL, a new concentration...
-
Lire la version française BOUCHERVILLE, Quebec, Dec. 2, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada is pleased to announce the launch of T/CLorazepam Injection USP 2 mg/mL, a new concentration now...
-
Version française BOUCHERVILLE, Quebec, Oct. 14, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada, which established a milestone in transparency by providing the first national report on availability...